Division of Accounting
The Division of Accounting is responsible for the analysis, reconciliation and preparation of financial statements generated from the internal FDA accounting system and presented in statements that conform to Government-wide standards. The FDA Division of Accounting has the overall responsibility for the administration, functional leadership and technical direction of an accounting system subject to managing FDA's multi-million dollar budget, including oversight of 26 District Offices nationwide.
The FDA accounting system is one of five recognized General Ledger/Financial Management systems in the Department of Health and Human Services. FDA is considered Agency Level and reports directly to OMB, Treasury and DHHS. All reports are subject to review and audit by GAO and the Inspector General.
The Division of Accounting is composed of two branches, the CFO Liaison Branch and the Accounting Services Branch.
The Chief Financial Officers (CFO) Liaison Branch is responsible for the FDA's annual financial statement audit and produces FDA's Chief Financial Officer's Annual Report. Created in FY 2000, this branch deals with the ever increasing demands of the annual audit.
The Accounting Services Branch is comprised of the following:
- Accounting Reports and Analysis Section
- Property Team
- Special Services Team (Applications, Obligations, IPAC, Support)